Classifying antibiotics in the WHO Essential Medicines List for optimal use-be AWaRe

Affiliations

¹ Paediatric Infectious Diseases Research Group, Institute for Infection and Immunity, St George's, University of London, London, UK.
² EA 4360 APEMAC, University of Lorraine, Nancy, France; Department of Infectious Diseases, Centre Hospitalier Régional Universitaire (CHRU) de Nancy, Nancy, France.
³ Infection Control Programme, University of Geneva Hospitals, Geneva, Switzerland; Department of Internal Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
⁴ Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai, China.
⁵ Centre for Disease Dynamics, Economics & Policy, New Delhi, India.
⁶ Department of Essential Medicines and Health Products, World Health Organization, 1211 Geneva 27, Switzerland. Electronic address: magrinin@who.int.

Mike Sharland et al. Lancet Infect Dis. 2018 Jan.

. 2018 Jan;18(1):18-20.

doi: 10.1016/S1473-3099(17)30724-7. Epub 2017 Dec 20.

¹ Paediatric Infectious Diseases Research Group, Institute for Infection and Immunity, St George's, University of London, London, UK.
² EA 4360 APEMAC, University of Lorraine, Nancy, France; Department of Infectious Diseases, Centre Hospitalier Régional Universitaire (CHRU) de Nancy, Nancy, France.
³ Infection Control Programme, University of Geneva Hospitals, Geneva, Switzerland; Department of Internal Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
⁴ Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai, China.
⁵ Centre for Disease Dynamics, Economics & Policy, New Delhi, India.
⁶ Department of Essential Medicines and Health Products, World Health Organization, 1211 Geneva 27, Switzerland. Electronic address: magrinin@who.int.

No abstract available

MeSH terms